Ra Pharmaceuticals Inc

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Donchian Channels



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 29 14.0 0.34% 0.50% 18.0% -4.9% 82.1%
SHORT 30 12.3 0.13% 0.15% 5.8% -5.3% -119.3%


Technical Analysis

Ra Pharmaceuticals Inc (RARX)



Last Signal:


Trading: HOLD @ $46.86
Signal Strength: STRONG

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.

Ra Pharmaceuticals Inc (NASDAQ:RARX) is currently bullish highlighting the potential for a short term trend continuation in the upward direction.

The Donchian channel is a useful indicator for seeing the volatility of a market price. If a price is stable the Donchian channel will be relatively narrow. If the price fluctuates a lot the Donchian channel will be wider. The two outer bands are plotted as the highest high and lowest low for a set period originally 20 days with the optional middle band calculated as the average of the two.

Calculation: Donchian Channels:
1) Upper Channel = 20 Day High;
2) Lower Channel = 20 Day Low;
3) Middle Channel = (20 Day High + 20 Day Low)/2;

PROFILE: Ra Pharmaceuticals Inc (RARX)

Stock Exchange: NASDAQ
Company: Ra Pharmaceuticals Inc
Ticker Codes: | RARX | NASDAQ:RARX |

About Ra Pharmaceuticals Inc (NASDAQ:RARX):

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); and is in Phase II clinical trial for treating patients with generalized myasthenia gravis (gMG), as well as in Phase 1b clinical trial for treating atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN). The company's preclinical testing products include Factor D inhibition for orphan renal and dense deposit diseases, and C3 glomerulonephritis; Oral C5 inhibitor for PNH, gMG, aHUS, LN, and central nervous system (CNS) diseases; and other complement inhibitors for autoimmune/CNS diseases. It has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Top 10:

Donchian Channels

Company Close Change(%) Volume Value Signal
INO Inovio Pharma 3.84 11.6 12,215,392 27.39 BULLISH
NVAX Novavax Inc 7.66 8 16,617,930 13.24 BULLISH
CTXS Citrix Systems Inc 128.48 7.8 3,900,635 39.9 BULLISH
INTC Intel Corp 67.49 7.6 40,092,378 50 BULLISH
ADRO Aduro Biotech 1.59 7.4 1,186,588 50 BULLISH
JBLU Jetblue Airways 21.07 6.4 15,757,756 47.38 BULLISH
PFBC Preferred Bank 63.98 6.4 274,903 41.95 BULLISH
MESO Mesoblast Ads 10.57 5.8 172,816 48.88 BULLISH
MBUU Malibu Boats 43.99 5.7 198,176 46.56 BULLISH
NVEE Nv5 Global 60.14 5.1 352,073 47.16 BULLISH